Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease

BACKGROUND: Sorafenib is the recommended treatment for advanced hepatocellular carcinoma (HCC), but transarterial chemoembolization (TACE) is performed in individual cases with limited extrahepatic spread. The aim of this study was to compare the outcome of patients with HCC and extrahepatic disease...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:United European Gastroenterol J
Main Authors: Kirstein, Martha M, Voigtländer, Torsten, Schweitzer, Nora, Hinrichs, Jan B, Marquardt, Jens, Wörns, Marcus-Alexander, Kloeckner, Roman, Fründt, Thorben W, Ittrich, Harald, Wacker, Frank, Rodt, Thomas, Manns, Michael P, Wege, Henning, Weinmann, Arndt, Vogel, Arndt
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833223/
https://ncbi.nlm.nih.gov/pubmed/29511553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640617716597
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados